Spectranetics to boost Stellarex spend

Spectranetics says it plans to boost its R&D spend on the Stellarex drug-eluting balloon it bought from Covidien.

Covidien, Spectranetics Corp.

News Well, MassDevice.com Earnings Roundup, 2015, Drug-Eluting Balloons, Q1

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1OliPt3